Yuan & Boehringer’s agreement renewal on major products

Published: 2016-12-22 14:25:48

Updated: 2016-12-22 14:25:48

On the 20^th, Yuhan Corporation(CEO Jung-Hee Lee) announced a strategic agreement for Korean marketing, sales and distribution of Boehringer Ingelheim’s major products with Boehringer Ingelheim(CEO Ki-Hwan Park).

Under the strategic agreement, Yuhan Corporation and Boehringer Ingelheim Korea will jointly promote and sell the antihypertensive Twynsta, the Trajenta family including Trajenta and T...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.